Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis (vol 3 VDAA082 2021)

被引：0
|
作者：
Alnahhas, Iyad [4 ]
Alsawas, Mouaz [2 ]
Rayi, Appaji [1 ]
Palmer, Joshua D. [3 ]
Raval, Raju [3 ]
Ong, Shirley [1 ]
Giglio, Pierre [1 ]
Murad, Mohammad Hassan [2 ]
Puduvalli, Vinay [1 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Div Neurooncol, Columbus, OH 43210 USA
[2] Mayo Clin, Evidence Based Practice Ctr, Rochester, MN USA
[3] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA
[4] Thomas Jefferson Univ, Dept Neurol, Div Neurooncol, 901 Walnut St,Room 310G, Philadelphia, PA 19107 USA
来源：
NEURO-ONCOLOGY ADVANCES | 2021年 / 3卷 / 01期
关键词：
D O I：
10.1093/noajnl/vdab095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 14 条
  • [1] Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis
    Alnahhas, Iyad
    Alsawas, Mouaz
    Rayi, Appaji
    Palmer, Joshua D.
    Raval, Raju
    Ong, Shirley
    Giglio, Pierre
    Murad, Mohammad Hassan
    Puduvalli, Vinay
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [2] MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis
    Chen, Yang
    Hu, Fulan
    Zhou, Yiheng
    Chen, Wangyang
    Shao, Hongying
    Zhang, Ying
    ARCHIVES OF MEDICAL RESEARCH, 2013, 44 (04) : 281 - 290
  • [3] MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review
    Brandner, Sebastian
    McAleenan, Alexandra
    Kelly, Claire
    Spiga, Francesca
    Cheng, Hung-Yuan
    Dawson, Sarah
    Schmidt, Lena
    Faulkner, Claire L.
    Wragg, Christopher
    Jefferies, Sarah
    Higgins, Julian P. T.
    Kurian, Kathreena M.
    NEURO-ONCOLOGY, 2021, 23 (09) : 1457 - 1469
  • [4] Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis
    Suh, C. H.
    Kim, H. S.
    Jung, S. C.
    Choi, C. G.
    Kim, S. J.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (08) : 1439 - 1445
  • [5] THE SURVIVAL BENEFIT OF VALPROIC ACID IN GLIOBLASTOMA TRENDS AWAY FROM SIGNIFICANCE WITH NEWER STUDIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Lu, Victor
    Texakalidis, Pavlos
    McDonald, Kerrie
    NEURO-ONCOLOGY, 2018, 20 : 84 - 84
  • [6] RETRACTION: RUNX3 Expression Level Is Correlated with the Clinical and Pathological Characteristics in Endometrial Cancer: A Systematic Review and Meta-analysis (Retraction of Vol 2021, art no 9995384, 2021)
    Liu, Z.
    Hong, Z.
    Xi, S.
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [7] Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis (vol 13, 5349, 2021)
    Fondevila, Flavia
    Fernandez-Palanca, Paula
    Mendez-Blanco, Carolina
    Payo-Serafin, Tania
    Lozano, Elisa
    Marin, Jose J. G.
    Gonzalez-Gallego, Javier
    Mauriz, Jose L.
    CANCERS, 2025, 17 (03)
  • [8] RETRACTED: Comment on - Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis (Retracted article. See vol. 48, 2025)
    Chellapandian, Hethesh
    Jeyachandran, Sivakamavalli
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [9] Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (vol 4, vdac075, 2022)
    Waqar, Mueez
    Roncaroli, Federico
    Lehrer, Eric J.
    Palmer, Joshua D.
    Villanueva-Meyer, Javier
    Braunstein, Steve
    Hall, Emma
    Aznar, Marianne
    Hamer, Philip C. De Witt
    D'Urso, Pietro I.
    Trifiletti, Daniel
    Quinones-Hinojosa, Alfredo
    Wesseling, Pieter
    Borst, Gerben R.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [10] Intracerebral haemorrhage volume, haematoma expansion and 3-month outcomes in patients on antiplatelets. A systematic review and meta-analysis (vol 6, pg 333, 2021)
    Goeldlin, M. B.
    Siepen, B. M.
    Mueller, M.
    EUROPEAN STROKE JOURNAL, 2023, 8 (01) : 400 - 400
12